Literature DB >> 21447890

Preventing work-related musculoskeletal disorders in Cuba, an industrially developing country.

Yaniel Torres1, Yordán Rodríguez, Silvio Viña.   

Abstract

OBJECTIVES: This paper briefly describes the history of ergonomics in Cuba and also presents some ergonomic interventions carried out in major economic sectors, focused on reducing musculoskeletal risk factors.
METHODS: Five studies concerning musculoskeletal risk factors were reviewed comparing the results of various ergonomic tools. Cuban legislation related to occupational health as well as statistics available on musculoskeletal disorders were examined.
RESULTS: The reviewed studies were carried out using such universally recognized assessment tools as RULA, Strain Index, OWAS and NIOSH equations as well as human movement analysis software. The interventions presented are examples of a proactive approach to the improvement of workers' health. Musculoskeletal disorders are responsible for the second highest rate of total permanent disability in the Cuban work force.
CONCLUSIONS: The prevailing approach to workers' health in terms of musculoskeletal disorders is basically reactive rather than proactive despite the commitment of the Cuban Government to the subject and a set of rules established to accomplish this goal. Simple tools for conducting a systematic evaluation of working conditions are needed in our context.

Entities:  

Mesh:

Year:  2011        PMID: 21447890     DOI: 10.3233/WOR-2011-1133

Source DB:  PubMed          Journal:  Work        ISSN: 1051-9815


  2 in total

1.  A method for non-experts in assessing exposure to risk factors for work-related musculoskeletal disorders--ERIN.

Authors:  Yordán Rodríguez; Silvio Viña; Ricardo Montero
Journal:  Ind Health       Date:  2013-09-27       Impact factor: 2.179

Review 2.  Musculoskeletal disorders: OWAS review.

Authors:  Marta Gómez-Galán; José Pérez-Alonso; Ángel-Jesús Callejón-Ferre; Javier López-Martínez
Journal:  Ind Health       Date:  2017-05-09       Impact factor: 2.179

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.